Xcout Intel
Brenus Pharma competitors & alternatives
The 12 closest competitors and alternatives to Brenus Pharma among biotechnology companies — ranked by similarity to what Brenus Pharma actually does, not by market-cap band.
Subscribe to see Brenus Pharma’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Brenus Pharma
Brenus Pharma is a pioneering clinical-stage biotech company headquartered in Clermont-Ferrand, France. The firm focuses on developing innovative immunotherapies aimed at preventing cancer recurrence and addressing solid tumors.
Brenus Pharma at a glance
Brenus Pharma is a biotechnology company headquartered in France. Its most recent funding round, Series A, raised $12.6M in July 2026. Xcout tracks 22 named people at Brenus Pharma, including Paul Bravetti (Chief Executive Officer).
Brenus Pharma leadership
- Paul BravettiChief Executive Officer
- Eric DessertennePresident and Chairman
- Aymeric BordetChief Financial Officer
- Benoit PinteurCO-Founder & CSO
- Jacques GardetteCo-Founder
- Herve GisserotGeneral Manager of CSL Vifor
16 more named people on record for Brenus Pharma, with roles, board committees and tenure — see the full roster →
Brenus Pharma funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $12.6M | 9 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Brenus Pharma competitors
Ranked by semantic similarity — how close each company is to Brenus Pharma by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
ImmunOs Therapeutics AG is a biotechnology company that develops treatments for cancer and inflammatory diseases by harnessing the human immune system. The company focuses on immuno-oncology and autoimmune therapies through a dedicated drug pipeline.
Similar biotechnology company
Brenig Therapeutics, Inc. is a clinical-stage biotechnology and drug development company focused on advancing small-molecule therapies.
Similar biotechnology company
Hephaitos Pharma is a preclinical-stage biotech company founded in 2018 and headquartered in Orsay, France. Backed by investors such as Elaia and the Fournier-Majoie Foundation, the firm focuses on developing the next generation of immunotherapies for cancer treatment. It operates as a privately held developer in the European life sciences sector.
Similar biotechnology company
Apmonia Therapeutics is a biotechnology company headquartered in Reims, France, committed to developing innovative therapeutic strategies for multiple types of cancer. Operating from its headquarters on Esplanade Roland, the firm advances oncology-focused drug candidates to target tumor progression. It is an active participant in the French biotech and life sciences ecosystem.
Similar biotechnology company
Agenus Inc. is a biotechnology company headquartered in Lexington, Massachusetts, focused on the discovery and development of better immunotherapies and cancer treatments.
Biotech
Lytix Biopharma is a clinical-stage biotechnology company developing oncolytic molecule therapies to treat superficial and deep-seated tumors. The company focuses on the neoadjuvant setting, providing first-in-class immunotherapies designed to destroy cancer cell membranes and stimulate a broad immune response.
Similar biotechnology company
Celyad Oncology is a biopharmaceutical company headquartered in Mont-Saint-Guibert, Belgium, focused on the development of innovative therapies.
Similar biotechnology company
Breakthru Medicine is a privately held biotechnology company headquartered in Phoenix, Arizona. Founded in 2024 by oncology experts, the company advances a portfolio of innovative cancer therapeutics designed to address critical unmet clinical needs.
Similar biotechnology company
Checkmate Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company headquartered in Cambridge, Massachusetts, focused on developing proprietary technology to stimulate the immune system to combat cancer.
Biotech
Calidi Biotherapeutics, Inc. is a clinical-stage biotechnology company focused on immuno-oncology, dedicated to developing advanced immunotherapies for various cancers. The company's innovative approach centers on utilizing powerful, allogeneic (donor-derived) stem cells as specialized carriers for anti-tumor agents. This technology is being advanced to address a range of oncological conditions, including aggressive brain tumors (high-grade gliomas) and other solid malignancies. Calidi's proprietary cell-based delivery systems are expertly designed to safeguard, amplify, and boost the therapeutic effects of oncolytic viruses. This strategic delivery method aims to achieve superior treatment efficacy and enhance patient safety. The company's clinical pipeline features two primary candidates: NeuroNova, which employs allogeneic neural stem cells loaded with an oncolytic adenovirus specifically for the treatment of high-grade gliomas; and SuperNova, which utilizes allogeneic adipose-derived mesenchymal stem cells to deliver the tumor-selective CAL1 oncolytic vaccinia virus for advanced metastatic solid tumors. Established in 2014, Calidi Biotherapeutics operates out of San Diego, California.
Similar biotechnology company
Avammune Therapeutics is an R&D-driven drug discovery company headquartered in Philadelphia, Pennsylvania. The company focuses on developing novel, modality-agnostic immunotherapies and cancer therapies to address high unmet medical needs in hard-to-treat solid tumors.
Biotech
RenovoRx, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing therapies for solid tumor malignancies. The company's primary investigational therapy, RenovoGem, is an innovative drug and device combination. It integrates intra-arterial gemcitabine with the RenovoCath system, currently progressing through pivotal Phase III clinical trials for the treatment of locally advanced pancreatic cancer. Established in 2009, RenovoRx, Inc. maintains its headquarters in Los Altos, California.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Brenus Pharma and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Brenus Pharmaand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →